ADHERENCE TO INSULIN IN SINGAPOREAN PEDIATRIC TYPE 1 DIABETES PATIENTS AND ITS IMPACT ON GLYCEMIC CONTROL AND HEALTHCARE UTILIZATION

  • Brandon Chua KKH Women's and Children's Hospital
  • Xin Yan Lim
  • Kar Men Poh
  • Jamie Stephanie Caleb
  • McVin Cheen
  • Soo Ting Lim
  • Ngee Lek

Abstract

Objective: Optimizing glycemic control is challenging with insulin nonadherence. This study aimed to characterize the prevalence of nonadherence among Singaporean pediatric patients with type 1 diabetes mellitus (T1DM) and investigate its associated outcomes.


Materials and methods: Singaporean patients with T1DM aged ≤18 years old with ≥1 year of insulin prescription between 2012 and 2016 were included in this retrospective, single-center longitudinal study. Patients on insulin pump were excluded. Nonadherence was defined as medication possession ratio (MPR) <100%. Glycemic control was defined using mean HbA1c within the study period. Healthcare utilization was defined as the number of outpatient, inpatient and emergency visits. The t-test, χ2 test, logistic regression and Poisson regression were used to analyze means, proportions, factors associated with nonadherence and association of nonadherence and healthcare utilization, respectively. Sensitivity analyses were performed for MPR thresholds of 80% and 95%.


Results: A total of 206 patients were included in this study. Nonadherent patients were older, had longer duration of diabetes since diagnosis and shorter duration of follow-up. Gender, race, financial class and number of concurrent medications were comparable between both groups. The prevalence of nonadherence was 34.0% (95% CI:27.9%–40.7%). Nonadherent patients had a higher average HbA1c (nonadherent:9.6%[2.1] vs adherent:8.6%[1.3], p<0.001). Nonadherence was not associated with healthcare utilization. Patients with >5 years of diabetes were more for likely to be nonadherent.


Conclusion: Nonadherence defined as MPR <100% is associated with poorer glycemic control. Further interventions may focus on patients with >5 years of diabetes to improve their adherence to insulin therapy.

Keywords: Adherence, Insulin, Pediatrics, Type 1 diabetes, Healthcare Utilization, Glycemic control, Medication possession ratio

References

1. International Diabetes Federation. Diabetes Atlas. 8th ed. International Diabetes Federation; 2017. Available from: http://www.diabetesatlas.org.
2. Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am 2010;39:481-97.
3. D Schwartz D, D Cline V, A Hansen J, E Axelrad M, J Anderson B. Early risk factors for nonadherence in pediatric type 1 diabetes: a review of the recent literature. Curr Diabetes Rev 2010;6:167-83.
4. Nathan DM, Group DER. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes care 2014;37:9-16.
5. McEwan P, Bennett H, Bolin K, Evans M, Bergenheim K. Assessing the economic value of maintained improvements in Type 1 diabetes management, in terms of HbA1c, weight and hypoglycaemic event incidence. Diabetic Med 2018;35:557-66.
6. Clifford S, Perez-Nieves M, Skalicky AM, Reaney M, Coyne KS. A systematic literature review of methodologies used to assess medication adherence in patients with diabetes. Curr Med Res Opin 2014;30:1071-85.
7. Stolpe S, Kroes MA, Webb N, Wisniewski T. A systematic review of insulin adherence measures in patients with diabetes. J Manag Care Spec Pharm 2016;22:1224-46.
8. Cheen HHM, Lim SH, Huang MC, Bee YM, Wee HL. Adherence to premixed insulin in a prefilled pen compared with a vial/syringe in people with diabetes in Singapore. Clin Ther 2014;36:1043-53.
9. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97.
10. Peterson AM, Nau DP, Cramer JA, Benner J, Gwadry?Sridhar F, Nichol M. A checklist for medication compliance and persistence studies using retrospective databases. Value Health 2007;10:3-12.
11. Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM, Newton RW, et al. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. Lancet 1997;350:1505-10.
12. Ying CL, Shah NM. Adherence to insulin treatment in children with type I diabetes mellitus at a hospital in Malaysia. Asian J Pharm Clin Res 2017;10:356-61.
13. Naing L, Winn T, Rusli B. Practical issues in calculating the sample size for prevalence studies. Arch Orofac Sci 2006;1:9-14.
14. Gandhi K, Vu B-MK, Eshtehardi SS, Wasserman RM, Hilliard ME. Adherence in adolescents with Type 1 diabetes: strategies and considerations for assessment in research and practice. Diabetes Manag (Lond) 2015;5:485.
15. Hood KK, Peterson CM, Rohan JM, Drotar D. Association between adherence and glycemic control in pediatric type 1 diabetes: a meta-analysis. Pediatr 2009;124:e1171-e9.
16. Borus JS, Laffel L. Adherence challenges in the management of type 1 diabetes in adolescents: prevention and intervention. Curr Opin Pediatr 2010;22:405.
17. Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int 2015;2015:1-12.
18. Gellad WF, Thorpe CT, Steiner JF, Voils CI. The myths of medication adherence. Pharmacoepidemiol Drug Saf 2017;26:1437-41.
19. Clifford S, Coyne KS. What is the value of medication adherence? J Manag Care Pharm 2014;20:650–1.
20. Sutton SS, Hardin JW, Bramley TJ, D'Souza AO, Bennett CL. Single-versus multiple-tablet HIV regimens: adherence and hospitalization risks. Am J Manag Care 2016;22:242-8.
Statistics
18 Views | Downloads
How to Cite
Chua, B., X. Y. Lim, K. M. Poh, J. S. Caleb, M. Cheen, S. T. Lim, and N. Lek. “ADHERENCE TO INSULIN IN SINGAPOREAN PEDIATRIC TYPE 1 DIABETES PATIENTS AND ITS IMPACT ON GLYCEMIC CONTROL AND HEALTHCARE UTILIZATION”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 12, no. 12, Oct. 2019, https://innovareacademics.in/journals/index.php/ajpcr/article/view/35558.
Section
Original Article(s)